last data update: 2011/10/17, 17:29

Website loading time

during the test: 0.44 s

cable connection (average): 0.59 s

DSL connection (average): 0.75 s

modem (average): 8.9 s

HTTP headers

Information about DNS servers

fiercebiotech.comSOAns0.dnsmadeeasy.comdns.dnsmadeeasy.com200601016643200 3600 1209600 180 IN 43200
fiercebiotech.comTXTv=spf1 ip4:208.95.132.73 ip4:208.66.206.23 mx a:fiercemarkets.com -allArrayIN21600
fiercebiotech.comMX5alt2.aspmx.l.google.comIN21600
fiercebiotech.comMX10aspmx2.googlemail.comIN21600
fiercebiotech.comMX10aspmx3.googlemail.comIN21600
fiercebiotech.comMX10aspmx4.googlemail.comIN21600
fiercebiotech.comMX1aspmx.l.google.comIN21600
fiercebiotech.comMX5alt1.aspmx.l.google.comIN21600
fiercebiotech.comA74.205.46.249IN21600
fiercebiotech.comNSns3.dnsmadeeasy.comIN43200
fiercebiotech.comNSns1.dnsmadeeasy.comIN43200
fiercebiotech.comNSns2.dnsmadeeasy.comIN43200
fiercebiotech.comNSns0.dnsmadeeasy.comIN43200
fiercebiotech.comNSns4.dnsmadeeasy.comIN43200

Received from the first DNS server

Request to the server "fiercebiotech.com"
You used the following DNS server:
DNS Name: ns3.dnsmadeeasy.com
DNS Server Address: 208.80.125.2#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 34606
flag: qr aa rd REQUEST: 1, ANSWER: 14, AUTHORITY: 0, ADDITIONAL: 0

REQUEST SECTION:
fiercebiotech.com. IN ANY

ANSWER SECTION:
fiercebiotech.com. 86400 IN NS ns1.dnsmadeeasy.com.
fiercebiotech.com. 86400 IN NS ns4.dnsmadeeasy.com.
fiercebiotech.com. 86400 IN NS ns0.dnsmadeeasy.com.
fiercebiotech.com. 86400 IN NS ns2.dnsmadeeasy.com.
fiercebiotech.com. 86400 IN NS ns3.dnsmadeeasy.com.
fiercebiotech.com. 21600 IN A 74.205.46.249
fiercebiotech.com. 21600 IN MX 10 aspmx2.googlemail.com.
fiercebiotech.com. 21600 IN MX 10 aspmx3.googlemail.com.
fiercebiotech.com. 21600 IN MX 10 aspmx4.googlemail.com.
fiercebiotech.com. 21600 IN MX 1 aspmx.l.google.com.
fiercebiotech.com. 21600 IN MX 5 alt1.aspmx.l.google.com.
fiercebiotech.com. 21600 IN MX 5 alt2.aspmx.l.google.com.
fiercebiotech.com. 21600 IN TXT "v=spf1 ip4:208.95.132.73 ip4:208.66.206.23 mx a:fiercemarkets.com -all"
fiercebiotech.com. 86400 IN SOA ns0.dnsmadeeasy.com. dns.dnsmadeeasy.com. 2006010166 43200 3600 1209600 180

Received 429 bytes from address 208.80.125.2#53 in 7 ms

Received from the second DNS server

Request to the server "fiercebiotech.com"
You used the following DNS server:
DNS Name: ns1.dnsmadeeasy.com
DNS Server Address: 208.80.124.2#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 59396
flag: qr aa rd REQUEST: 1, ANSWER: 14, AUTHORITY: 0, ADDITIONAL: 0

REQUEST SECTION:
fiercebiotech.com. IN ANY

ANSWER SECTION:
fiercebiotech.com. 86400 IN NS ns4.dnsmadeeasy.com.
fiercebiotech.com. 86400 IN NS ns1.dnsmadeeasy.com.
fiercebiotech.com. 86400 IN NS ns2.dnsmadeeasy.com.
fiercebiotech.com. 86400 IN NS ns0.dnsmadeeasy.com.
fiercebiotech.com. 86400 IN NS ns3.dnsmadeeasy.com.
fiercebiotech.com. 21600 IN A 74.205.46.249
fiercebiotech.com. 21600 IN MX 10 aspmx2.googlemail.com.
fiercebiotech.com. 21600 IN MX 10 aspmx3.googlemail.com.
fiercebiotech.com. 21600 IN MX 10 aspmx4.googlemail.com.
fiercebiotech.com. 21600 IN MX 1 aspmx.l.google.com.
fiercebiotech.com. 21600 IN MX 5 alt1.aspmx.l.google.com.
fiercebiotech.com. 21600 IN MX 5 alt2.aspmx.l.google.com.
fiercebiotech.com. 21600 IN TXT "v=spf1 ip4:208.95.132.73 ip4:208.66.206.23 mx a:fiercemarkets.com -all"
fiercebiotech.com. 86400 IN SOA ns0.dnsmadeeasy.com. dns.dnsmadeeasy.com. 2006010166 43200 3600 1209600 180

Received 429 bytes from address 208.80.124.2#53 in 7 ms

Subdomains (the first 50)

Typos (misspells)

diercebiotech.com
ciercebiotech.com
viercebiotech.com
giercebiotech.com
tiercebiotech.com
riercebiotech.com
fuercebiotech.com
fjercebiotech.com
fkercebiotech.com
foercebiotech.com
f9ercebiotech.com
f8ercebiotech.com
fiwrcebiotech.com
fisrcebiotech.com
fidrcebiotech.com
firrcebiotech.com
fi4rcebiotech.com
fi3rcebiotech.com
fieecebiotech.com
fiedcebiotech.com
fiefcebiotech.com
fietcebiotech.com
fie5cebiotech.com
fie4cebiotech.com
fierxebiotech.com
fiervebiotech.com
fierfebiotech.com
fierdebiotech.com
fiercwbiotech.com
fiercsbiotech.com
fiercdbiotech.com
fiercrbiotech.com
fierc4biotech.com
fierc3biotech.com
fierceviotech.com
fierceniotech.com
fiercehiotech.com
fiercegiotech.com
fiercebuotech.com
fiercebjotech.com
fiercebkotech.com
fiercebootech.com
fierceb9otech.com
fierceb8otech.com
fiercebiitech.com
fiercebiktech.com
fiercebiltech.com
fiercebiptech.com
fiercebi0tech.com
fiercebi9tech.com
fiercebiorech.com
fiercebiofech.com
fiercebiogech.com
fiercebioyech.com
fiercebio6ech.com
fiercebio5ech.com
fiercebiotwch.com
fiercebiotsch.com
fiercebiotdch.com
fiercebiotrch.com
fiercebiot4ch.com
fiercebiot3ch.com
fiercebiotexh.com
fiercebiotevh.com
fiercebiotefh.com
fiercebiotedh.com
fiercebiotecg.com
fiercebiotecb.com
fiercebiotecn.com
fiercebiotecj.com
fiercebiotecu.com
fiercebiotecy.com
iercebiotech.com
fercebiotech.com
fircebiotech.com
fiecebiotech.com
fierebiotech.com
fiercbiotech.com
fierceiotech.com
fiercebotech.com
fiercebitech.com
fiercebioech.com
fiercebiotch.com
fiercebioteh.com
fiercebiotec.com
ifercebiotech.com
feircebiotech.com
firecebiotech.com
fiecrebiotech.com
fierecbiotech.com
fiercbeiotech.com
fierceibotech.com
fierceboitech.com
fiercebitoech.com
fiercebioetch.com
fiercebiotceh.com
fiercebiotehc.com
ffiercebiotech.com
fiiercebiotech.com
fieercebiotech.com
fierrcebiotech.com
fierccebiotech.com
fierceebiotech.com
fiercebbiotech.com
fiercebiiotech.com
fiercebiootech.com
fiercebiottech.com
fiercebioteech.com
fiercebiotecch.com
fiercebiotechh.com

Location

IP: 74.205.46.249

continent: NA, country: United States (USA), city: Washington

Website value

rank in the traffic statistics:

There is not enough data to estimate website value.

Basic information

website build using CSS

code weight: 59.21 KB

text per all code ratio: 19 %

title: Biotech Industry, Biotech News, Biotechnology Articles --- Fierce Biotech

description: Read the latest biotechnology articles on biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news.

keywords: biotech industry, biotechnology articles, biotech industry news, fda approval news, biotech company, fiercebiotech, biotech news, clinical trials, drug discovery, fda approval, fda regulation, stem cell research, biotechnology news, biotechnology industry

encoding: utf-8

language: en

Website code analysis

one word phrases repeated minimum three times

PhraseQuantity
Clinical9
and8
Biotech6
in5
Trial4
>>4
for4
Webinars3
Management3
Phase3
Studies3
3
of3
Jobs3
Events3
Biomarkers3

two word phrases repeated minimum three times

PhraseQuantity
Clinical Trial4

three word phrases repeated minimum three times

B tags

U tags

I tags

images

file namealternative text
FierceBiotech
FierceBiotech IT
FiercePharma
FierceMedicalDevices
FierceBiotech Research
FierceVaccines
FiercePharma Manufacturing
FierceDrugDelivery
Syndicate content
Clicky

headers

H1

Latest News

H2

Free Newsletter

Featured Resources

Webinars

Hottest Products

Featured Jobs

Popular Topics

Events

Top Story

Also Noted

Press Releases

Popular Comment Threads

Report

Special Report

Whitepapers

Paid Research Reports

H3

Free Newsletter

Featured Resources

Webinars

Hottest Products

Featured Jobs

Popular Topics

Events

Top Story

Also Noted

Press Releases

Popular Comment Threads

Report

Special Report

Whitepapers

Paid Research Reports

H4

H5

H6

internal links

addressanchor text
Contact
Help
Home
News
Features
Events
eBooks
Whitepapers
Webinars
Jobs
About
View Sample
Privacy
Mobile Edition
Emerging Drug Developers
2009 Fierce 15
Biotech Venture Capital
Deals in Biotech
Clinical Trial Results
Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series)
Active Directory & the Cloud for Biotech & Pharma
Special Studies in Cancer Patients: AME and Cardiac Safety
Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
More Webinars >>
Manager, Regulatory CMC Job
Director/Senior Director Project Management
Patient Support Specialist Job
Oracle Clinical, InForm Configuration
Director Regulatory Affairs Strategy - Pharma Products
More Jobs >>
FDA
Biotech Venture Capital
Phase III
biopharmaceutical company
GlaxoSmithKline
Pfizer
Phase II
pharmaceuticals
biotechnology company
Mergers and Acquisitions
Merck
Biotech deals
Novartis
FDA approval
More tags...
DIA/PhRMA Predictive Models of Human Pharmacokinetics Workshop
Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Biomarker Applications for Improved Clinical Trial Outcomes
Medical Device Complaint Handling: Building An Integrated Approach for Your Company
More Events >>
About
View Sample
Privacy
10 promising late-stage cancer drugs
Biotechs lug big risks with option-based pharma deals
Syndicate content
Vaccine startup banks $10M round for Ph1 study
KV back in spotlight as it levels charges, claims against ex-chief
Harvard project takes aim at improving drug development odds
Early-stage R&D takes center stage at FierceBiotech executive breakfast
Vivus gets back in the race for weight-loss drug OK, resubmits Qnexa
Working on a cure, Roche scoops up Anadys hep C drugs in $230M buyout
UPDATED: Sofinnova bucks a bleak trend with $440M biotech fund
Epizyme scores $4M in ongoing GSK alliance
Biotechs lug big risks with option-based pharma deals
Capstone Therapeutics axing 78% of jobs in 'hibernation' move
More news
Article
Read more >>
Curis to Present at the BioCentury NewsMakers in the Biotech Industry Conference
Cubist Pharmaceuticals Appoints Jennifer Jackson as Senior Vice President, Regulatory Affairs
CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India
Panmira Announces Appointment of New CEO
Sentrx Announces Resignation of Charles T. Saldarini As CEO
Marina Biotech, Inc. Announces a $15 Million Purchase Agreement With Lincoln Park Capital Fund, LLC
More Press Releases >>
Submit a press release
Biotech's 5 key attacks on pancreatic cancer
Report
The 2011 Fierce 15
See the 2011 Fierce 15 >>
More Whitepapers >>
Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
Home
Subscribe
Mobile Edition
RSS
Privacy
Site Map
Editors

external links

addressanchor text
Advertise
Biomarkers
Marketplace
Clinical Trial Management Software (CTMS)
Clinical Data Management Systems (CDMS)
Phase I Clinical Studies
Phase II Clinical Studies
Clinical Research Organizations (CRO)
Clinical Trial Monitoring
Evaluate more than 400,000 products >>
Item
@FierceBiotech
@JohnCFierce
Story
@RyanMFierce
Article
@MaureenFierce
Pharma News
APP Pharma boosts supply of propofol products
KV asks court to toss ex-CEO's $36.9M compensation
Jury clears J&J in another Levaquin injury case
Healthcare's budget-cutting idea: Target drug companies
Takeda's plate full with Nycomed integration
More >>
Biotech Research News
Harvard project takes aim at improving drug development odds
Chocolate – the miracle drug?
United Therapeutics wins $45M deal for oral antiviral
Natural compound shows promise as a pathway to diabetes pill
Diabetes science team finds a "negative regulator" for insulin secretion
More >>
Biotech IT News
Google Earth marks sources of infection
Robot scientist passes big bio test
Twitter opinions linked to vaccine uptake
Bayer tackles informatics challenges in cancer research
Accelrys brings drug discovery projects to the cloud
More >>
Vaccines News
Michael J. Fox Foundation bankrolls AFFiRiS Parkinson's vaccine
CA law lets tweens make HPV vaccination decisions
Inovio, VGX ink hep B and C vaccine deal
HepB vax Heplisav posts positive Ph3 data
Coridon HSV-2 vaccine shows 100% efficacy
More >>
Pharma Manufacturing News
GSK site pulls out all stops in plant-investment competition
Senate bill would ease FDA conflict-of-interest rule
Pain patch maker warned by FDA over validation reporting
China assesses illegal drug activities
Genzyme's Ireland site expanded
More >>
Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?
Podcasting Pioneering solution for online advertising
Commercial Insight: Top 20 Cancer Therapy Brands
Otava Lead-Like Library
BRAND-NEW COMPOUNDS
Biologically Active Molecules: Chemical Research, Development and Scale-up
List in Marketplace
Supplier in Marketplace
FierceEnergy
FierceSmartGrid
FierceFinance
FierceFinanceIT
FierceComplianceIT
FierceHealthFinance
FierceHealthIT
Hospital Impact
FierceMobileHealthcare
FierceHealthPayer
FiercePracticeManagement
FierceEMR
FierceCIO
FierceContentManagement
FierceMobileIT
FierceGovernmentIT
FierceGovernment
FierceHomelandSecurity
FierceBiotech Research
FiercePharma
FierceVaccines
FierceBiotechIT
FiercePharma Manufacturing
FierceMedicalDevices
FierceDrugDelivery
FierceIPTV
FierceTelecom
FierceEnterpriseCommunications
FierceBroadbandWireless
FierceDeveloper
FierceWireless
FierceWireless:Europe
FierceCable